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ABSTRACT
When double-strand breaks are introduced in a
genome by CRISPR they are repaired either by non-
homologous end joining (NHEJ), which often results
in insertions or deletions (indels), or by homology-
directed repair (HDR), which allows precise nu-
cleotide substitutions to be introduced if a donor
oligonucleotide is provided. Because NHEJ is more
efficient than HDR, the frequency with which precise
genome editing can be achieved is so low that simul-
taneous editing of more than one gene has hitherto
not been possible. Here, we introduced a mutation
in the human PRKDC gene that eliminates the ki-
nase activity of the DNA-dependent protein kinase
catalytic subunit (DNA-PKcs). This results in an in-
crease in HDR irrespective of cell type and CRISPR
enzyme used, sometimes allowing 87% of chromo-
somes in a population of cells to be precisely edited.
It also allows for precise editing of up to four genes
simultaneously (8 chromosomes) in the same cell.
Transient inhibition of DNA-PKcs by the kinase in-
hibitor M3814 is similarly able to enhance precise
genome editing.
INTRODUCTION
When CRISPR nucleases and guide RNAs (gRNAs) are
used to introduce double-stranded breaks (DSBs) in a
genome, the twoDNAends are covered byDNA-dependent
protein kinase (DNA-PK) complexes, which consist of
Ku70/80 and DNA-PKcs (1). DNA-PKcs then undergoes
conformational changes induced in part by autophospho-
rylation (2,3) as well as by other kinases (4,5) at >60 phos-
phorylation sites (6–8). This allows it to recruit NHEJ re-
pair proteins and inhibit HDR proteins, for example ataxia
telangiectasia mutated kinase (ATM), by phosphorylation
(6,9,10).DNAends can also be bound by theMRN (Mre11,
Rad50 and Nbs1) complex, which results in 5′-3′ resec-
tion of DNA ends and HDR or microhomology-mediated
end joining (MMEJ), also referred to as alternative NHEJ
(11,12). In the case of HDR, end resection is followed
by RAD51-nucleoprotein filament generation, annealing of
homologous DNA, and DNA synthesis (1,13). In case of
MMEJ repair, identical sequences of 1–16 nucleotide in the
single-stranded ends align to each other, followed by re-
moval of unaligned parts of the single-stranded ends, gap
filling DNA synthesis and ligation, resulting in a deletion at
the DSB site (12).
Because NHEJ introduce indels that can lead to
frameshift mutations it is often used to inactivate genes.
In contrast, HDR normally uses a sister chromatid to re-
pair the chromosome carrying a DNA break. If exogenous
‘donor’ DNA carrying desired mutations is provided, it is
possible to performprecise genome editing (PGE), i.e. intro-
duce desired nucleotide substitutions at specific positions in
a genome. Typically, NHEJ is more efficient than HDR and
has been used to knock out multiple target genes in cells,
for example five genes in mouse embryonic stem cells (14)
and 62 copies of one endogenous retrovirus in a porcine cell
line (15). In contrast, although several studies have tried to
inhibit NHEJ or enhance HDR in order to increase the ef-
ficiencies of PGE (16–20), simultaneous PGE of more than
one desired target in animal cells has not been reported, al-
though methods for co-selection of one desired edit by si-
multaneous introduction of a selectable modification at a
different locus have been developed (21,22). However, this
allows only a single desired target to be edited together with
the selectable marker.
Because simultaneous knockouts of several genes by
NHEJ is possible, DNA cleavage by the CRISPR enzymes
is not rate limiting for genome editing. Rather, it seems
that the higher efficiency of NHEJ relative to HDR limits
the ability to introduce precise edits. In 2008, it was shown
that a lysine to arginine mutation at position 3753 near the
ATP binding site in the DNA-PKcs protein (KR) abolishes
its kinase activity (13,23) in Chinese hamster ovary cells
and that this increases homologous recombination to levels
2- to 3-fold above those seen when DNA-PKcs was com-
pletely knocked down (23). Inactive but structurally intact
DNA-PKcs may increase homologous recombination be-
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cause phosphorylation of downstream NHEJ proteins as
well as phosphorylation-induced inhibition of ATM kinase
activity (9) is blocked, while ATM levels needed for effi-
cient HDR are maintained (23). In contrast, in the absence
of DNA-PKcs protein, levels of ATM and thus HDR are
reduced (13,24). Knock down of the DNA-PKcs protein
by siRNA (25), or in DNA-PKcs (-/-) cell line (26), could




We recently created an iCRISPR-Cas9n line from human
induced pluripotent stem cells (hiPSCs) (17) (409-B2, fe-
male, Riken BioResource Center) as described by Gonzalez
et al. (17,27) (GMO permit AZ 54-8452/26). For this study,
we further used HEK293 cells (ECACC, 85120602) with
Dulbecco’s modified Eagle’s medium/F-12 (Gibco, 31330-
038) supplemented with 10% fetal bovine serum (FBS)
(SIGMA,F2442) and 1%NEAA (SIGMA,M7145); as well
as K562 cells (ECACC, 89121407) with Iscove’s modified
Dulbecco’smedia (ThermoFisher, 12440053) supplemented
with 10% FBS. 409-B2 hiPSCs were grown on Matrigel
Matrix (Corning, 35248) in mTeSR1 medium (StemCell
Technologies, 05851) with supplement (StemCell Technolo-
gies, 05852) that was replaced daily. Medium for HEK293
and K562 was replaced every second day. At ∼80% conflu-
ency, adherent cells were dissociated using EDTA (VWR,
437012C) and split 1:6 to 1:10 in medium supplemented
with 10 M Rho-associated protein kinase (ROCK) in-
hibitor Y-27632 (Calbiochem, 688000) for 1 day after re-
plating. K562 cells were split 1:6 to 1:10 dilution after
1 week. All cells were grown at 37◦C in a humidified incu-
bator with 5% CO2.
Lipofection of oligonucleotides
409-B2 iCRISPR-Cas9n hiPSCs were incubated in medium
containing 2 g/ml doxycycline (Clontech, 631311) three
to 4 days prior to lipofection. Lipofection was done us-
ing the alt-CRISPR protocol (IDT) at a final concentra-
tion of 7.5 nM of each gRNA (crRNA/tracR duplex) and
10 nM of the DNA donors. In brief, 0.75 l RNAiMAX
(Invitrogen, 13778075) and the respective oligonucleotides
were separately diluted in 25 l OPTI-MEM (Gibco, 1985-
062) and incubated at room temperature for 5 min. Both
dilutions were mixed to yield 50 l of OPTI-MEM includ-
ing RNAiMAX, gRNAs and single stranded DNA donors
(ssODNs). The lipofectionmixwas incubated for 20–30min
at room temperature. Cells were dissociated using EDTA
for 5min and counted using the Countess Automated Cell
Counter (Invitrogen). The lipofection mix, 100 l contain-
ing 25 000 dissociated cells in mTeSR1 supplemented with
Y-27632, and 2 g/ml doxycycline were put in one well of
a 96-well covered with Matrigel Matrix (Corning, 35248).
Media was exchanged to regular mTeSR1 media after 24 h.
KATNA1, SLITRK1, and CALD1 were edited using lipo-
fection (Figure 1A and B). We also attempted multiplexed
editing of three genes simultaneously using lipofection, but
achieved 3–10% HDR for a gene at best.
Oligonucleotide and ribonucleoprotein electroporation
The recombinant Streptococcus pyogenesCas9 protein,Aci-
daminococcus sp. BV3L6 Cpf1 protein and respective elec-
troporation enhancer were from IDT (Coralville, USA) and
electroporation was done using the manufacturer’s proto-
col, except for the following alterations. Nucleofection was
done using the B-16 program of the Nucleofector 2b De-
vice (Lonza) in cuvettes for 100 l Human Stem Cell nu-
cleofection buffer (Lonza, VVPH-5022), containing 1 mil-
lion cells, 78pmol electroporation enhancer, 160 pmol of
each gRNA (crRNA/tracR duplex for Cas9 and crRNA
for Cpf1), 200 pmol of each single stranded DNA donor
(ssODN), and 252 pmol Cas9 or Cpf1. Cells were counted
using the Countess Automated Cell Counter (Invitrogen).
For multiplexing, only gRNAs and ssODNs were electro-
porated, since a Cas9n expressing iCRISPR-Cas9n hiPSC
line was used. 409-B2 iCRISPR-Cas9n hiPSCs were incu-
bated in medium containing 2 g/ml doxycycline (Clon-
tech, 631311) three to four days prior to editing. For multi-
plexed precise genome editing, this medium was exchanged
to StemFlex with supplement (Gibco, A3349401), CloneR
(StemCell Technologies, 05888), and doxycycline one day
before electroporation. 90% of the electroporated cells were
plated for bulk genotype analysis and for hiPSCs 10 percent
were plated in a separate 6well to give rise to colonies de-
rived from a single cell (clones) for which themediawas sup-
plemented with ROCK inhibitor Y-27632 for 2 days post-
electroporation. After at least 7 days colonies were picked
for following propagation and DNA isolation. Single cell
colonies of HEK293 and K562 cells were acquired by sort-
ing single cells in wells of a 96-well plate using a single-cell
printer (Cytena).
Illumina library preparation and sequencing
At least 3 days after transfection cells were dissociated us-
ing Accutase (SIGMA, A6964), pelleted, and resuspended
in 15 l QuickExtract (Epicentre, QE0905T). Incubation at
65◦C for 10 min, 68◦C for 5 min and finally 98◦C for 5 min
was performed to yield single strandedDNA as a PCR tem-
plate. Primers for each targeted loci containing adapters for
Illumina sequencing were from IDT (Coralville, USA) (see
Supplementary Table S1). PCR was done in a T100 Ther-
mal Cycler (Bio-Rad) using the KAPA2G Robust PCR Kit
(SIGMA, KK5024) with supplied buffer B and 3 l of cell
extract in a total volume of 25 l. The thermal cycling pro-
file of the PCR was: 95◦C 3 min; 34× (95◦C 15 s, 65◦C 15 s,
72◦C 15 s); 72◦C 60 s. P5 and P7 Illumina adapters with
sample specific indices were added in a second PCR reac-
tion (28) using Phusion HFMasterMix (Thermo Scientific,
F-531L) and 0.3 l of the first PCR product. The thermal
cycling profile of the PCR was: 98◦C 30 s; 25× (98◦C 10 s,
58◦C, 10 s, 72◦C 20 s); 72◦C 5 min. Amplifications were
verified by size separating agarose gel electrophoresis using
2%EXgels (Invitrogen,G4010–11). The indexed amplicons
were purified using Solid Phase Reversible Immobilization
(SPRI) beads in a 1:1 ratio of beads to PCR solution (29).
Double-indexed libraries were sequenced on a MiSeq (Il-
lumina) giving paired-end sequences of 2 × 150 bp (+7 bp
index). After base calling using Bustard (Illumina) adapters
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Figure 1. Catalytically inactive DNA-PKcs promotes homology-directed repair (HDR). (A) The genome editing frequencies with Cas9n and single
stranded DNA donors for 14 genes in the DNA-PKcs WT cell line; and (B) in the DNA-PKcs KR cell line. HDR, ‘mix’ (HDR with indels), NHEJ,
and MMEJ (≥2 bp microhomology) are indicated in green, light green, light blue and light purple, respectively. Error bars show the SEM of at least four
replicate experiments. (C) Increase in frequency of HDR (left) and relative to NHEJ and MMEJ (right). Each dot corresponds to one gene and the black
line shows the mean. (D) Percent of all deletions resulting fromMMEJ for the 14 genes as a function of microhomology length in KR andWT cells. Boxes
extend from the 25th to 75th percentile, show the median as a line and have whiskers from minimum to maximum values. (E) Schematic illustration of the
repair of DSBs. After a DSB induced, e.g. by a CRISPR enzyme, DNA ends are covered by Ku70/80 (orange), followed by binding of DNA-PKcs (cyan
blue), both constituting a DNA-PK complex. Autophosphorylation of DNA-PKcs leads to recruitment and activation of downstream NHEJ proteins. If
DNA-PKcs is catalytically inactivated (e.g. by the K3753R mutation), the NHEJ pathway is blocked and only MMEJ can compete with HDR.
Amplicon sequence analysis
Bam-files were demultiplexed and converted into fastq
files using SAMtools (31). CRISPResso (32) was used to
analyse fastq files for percentage of wildtype, any tar-
geted nucleotide substitution (HDR), indels (called as non-
homologous end joining NHEJ), and mix of both. Analysis
was restricted to amplicons with aminimumof 70% similar-
ity to the wildtype sequence and to a window of 20 bp from
each gRNA. Sequence homology for an HDR occurrence
was set to 95%. Unexpected substitutions were ignored as
putative sequencing errors. Since CRISPResso cannot dis-
tinguish reads with indels from NHEJ or microhomology-
mediated end joining (MMEJ), we wrote a python script
to call MMEJ events. Sequencing data from colonies de-
rived from single cell seeding (Figure 2D) was analyzed us-
ing SAMtools and colonies were regarded as clones if the
clear majority of reads consisted of a single sequence (ho-
mozygous) or of two sequences of similar read counts (het-
erozygous) and blocking mutations, ancient mutations, as
well as indels for each chromosome of the cells of a clone
were noted (Supplementary Tables S2–S5).
Whole genome sequencing
The 409-B2 iCRISPR-Cas9n hiPSCs WT line, KR clone
and KR-KSC line were expanded and two million cells of
the respective lines were harvested and DNA was isolated.
DNA was sonicated three times with a Bioruptor (Dio-
genode), with the output selector switched to (H)igh to
yield fragments of ∼0.15 to 0.8 kb. Shearing was checked
by agarose gel electrophoresis using EX gels (Invitrogen,
G4010–11) and a Typhoon 9410 imager (Amersham, Bio-
sciences). Fragment ends were made blunt for 30 min at
room temperature with the Quick Blunting Kit (New En-
gand Biolabs, E1201L), purified with SPRI beads (28),
adapter-ligated for 30 min at room temperature with the
Quick Ligation Kit (New England Biolabs, M2200L), puri-
fiedwith SPRI beads, double indexed by PCR-amplification
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Figure 2. Multiplexed precise genome editing using catalytically inactive DNA-PKcs. (A) Editing frequencies for single genes and combinations of two
out of four genes (framed). HDR, mix (HDR with indels), NHEJ, and MMEJ are indicated in green, light green, light blue and light purple, respectively.
(B) Editing frequencies for single genes and combinations of three genes (framed). (C) Editing frequencies for single genes and combinations of four or
five genes (framed). (D) Pie charts of the genotypes from single cell derived colonies after multiplexed editing of three combinations of three genes and one
of four genes. See Supplementary Tables S2–S5 for details. (E) Cell survival after editing of one to five genes. Resazurin assays were performed three days
after editing. Error bars show the SEM of four replicate experiments for A, B, C and D.The bold frame and bold dashed frame indicate that the targeted
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were sequenced on a HiSeq (Illumina) 2 × 75 bp (+7 bp
index) (Figure 3C and Supplementary Figure S3).
Mapping and genotyping
Reads were mapped to the human reference (hg19)
using Burrows-Wheeler Aligner (BWA) (33) default pa-
rameters. Genotyping was carried out using Genome
Analysis Toolkit (GATK) (34) (version 3.3-0-g37228af).
We indel realigned the BWA mapped bam files using
GATK IndelRealigner with default parameters. The
variant calling was carried out on the realigned bam files
by GATK HaplotypeCaller (java -jar GenomeAnaly-
sisTK.jar -T HaplotypeCaller -R human reference.fa -L
chromosome number –out output.vcf –I realigned.bam
–emitRefConfidence BP RESOLUTION –allSitePLs
–output mode EMIT ALL CONFIDENT SITES).
Genomic coverage calculation
Coverage along the chromosomes was calculated with
for 1Mb windows, using unique genomic regions
(wgEncodeDukeMapabilityUniqueness35bp=1) and




The variants called by GATK were filtered by removing
positions that overlap repeats annotated by the UCSC
genome browser and that might lead to ambiguous align-
ments (map35 100% filter from reference (36)). Genomic
positions with 30–50-fold coverage in all three lines were
used for downstream analysis. We required the absolute dif-
ference between the maximum and minimum alternate al-
lele frequency of a genotype in all three clones to be at least
30%. Finally, we inspected each genotype differences be-
tween lines using the Integrated Genome Viewer (IGV) (37)
and excluded obvious genotyping artefacts.
Resazurin assay
409B2-iCRISPR hiPSCs expressing DNA-PKcs wildtype
(WT), catalytically inactiveDNA-PKcs (K3753R), orK562
cells were plated (50 000/100 000 cells per well in a 24-well
plate). HiPSCs were grown for two days before treatment
with different Bleomycin (Sigma, B8416) concentrations for
1 h. Afterwards cells were washed three times. After recov-
ery for 72 h, 100l freshmedia together with 10l resazurin
solution (Cell Signaling, 11884) was added. Resazurin is
converted into fluorescent resorfin by cellular dehydroge-
nases and fluorescence (exitation: 530–570 nm, emission:
590–620 nm) reflects the amount of living cells (38). Cells
were incubated with resazurin at 37◦C for 5 h before flu-
orescence readings using a Typhoon 9410 imager (Amer-
shamn Biosciences) and quantification using ImageJ and
the ‘ReadPlate’ plugin. Wells with media and resazurin, but
without cells, were used a blank.
Karyotyping
Karyotyping by trypsin induced Giemsa staining (GTG)
or spectral karyotyping (SKY) were carried out accord-
ing to international quality guidelines (ISCN 2016: An In-
ternational System for Human Cytogenetic Nomenclature
(39)) by the ‘Sa¨chsischer Inkubator fu¨r klinische Transla-
tion’ (Leipzig, Germany).
Cellular clone genotype and target gene copy number analysis
409-B2 hiPSCs were edited in the FRMD7 gene using
Cas9 ribonucleoprotein and DNA donor electroporation
and cells were treated with or without 2 M M3814 for
3 days. After recovery for three days cells were sorted us-
ing a single-cell printer (Cytena) with hydrophobic car-
tridges to establish cellular clones. DNA extracts were
used for target amplification with PCR from which Illu-
mina libraries were made and sequenced. Amplicon se-
quence analysis was carried out as described above. To de-
termine FRMD7 copy number, a TaqMan assay was done
(ThermoFisher, 4400294, reporter target sequence: FAM-
TTGCAGTGGGCTCTACATAGC-NFQ; human RNAse
P copy number reference, ThermoFisher, 4403328; TaqMan
genotyping master mix, ThermoFisher, 4371355). Quanti-
tative PCR was carried out in a Stratagene MX3005P (Agi-
lent Technologies). Long range PCR (∼3 kb) of theFRMD7
locus was done in a T100 Thermal Cycler (Bio-Rad) using
the KAPA2G Robust PCR Kit (SIGMA, KK5024) with
buffer B and 3 l of DNA extract in a total volume of 25 l.
The thermal cycling profile of the PCR was: 95◦C 3 min;
30× (95◦ 15 s, 65◦C 15 s, 72◦C 60 s); 72◦C 60 s. Primers are
stated in Supplementary Table S1.
Statistical analysis
Bar graphs in figures were plotted and SEM error bars were
calculated using GraphPad Prism 6 software. The number
of replicates is stated in the respective figure legends.
RESULTS
Catalytically inactive DNA-PKcs promotes homology-
directed repair across cell types and CRISPR enzymes
To achieve high efficiency of targeted DSBs and reduce
off-target DSBs we previously generated a human induced
pluripotent stem cell (hiPSC) line carrying a doxycycline-
inducible Cas9 with the D10A mutation (iCRISPR-Cas9n)
causing it to generate nicks rather than double-stranded
cuts in DNA targets (17). In this line, we now intro-
duced the K3753R mutation in the PRKDC gene that en-
codes DNA-PKcs protein. We compared the efficiency with
which nucleotide substitutions can be introduced in DNA-
PKcs K3753R (KR) and DNA-PKcs wildtype (WT) cells.
To do this, we designed gRNAs (40) and single-stranded
oligodeoxynucleotide donors (ssODNs) to revert 14 substi-
tutions that are fixed or almost fixed among present-day hu-
mans but occur in the ancestral, ape-like states in the Ne-
andertal and Denisovan genomes (36) back to the ances-
tral states. When necessary, the ssODNs carried additional
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Figure 3. Genome stability of DNA-PKcs K3753R cells. (A) Schematic illustration of the cell lines used. A 409B2-iCRISPR iPSC line (gray) was edited
to express the DNA-PKcs KR (red) which was in turn used to edit three genes KATNA1, SLITRK1, and CALD1 to yield the KR-KSC line (blue). The
editing scheme and passaging times between clonal bottlenecks are shown. (B) Karyotypes analyzed byGiemsa staining (GTG) spectral karyotyping (SKY)
passage numbers are indicated. One polyploid metaphase was observed in the KR-KCS clone. (C) Genomic sequence coverage per chromosome in the
three cell lines. (D) Numbers of SNVs and indels in high-confidence genotypes (62.1Mb) of the three cell lines are given. Novel genotypes that appeared
first in the KR line (19) and KR-KSC (3) line, are colored red or blue, respectively.
the DNA once the targeted substitutions have been intro-
duced (Supplementary Table S1).
Following induction of expression of Cas9n by doxycy-
cline, cells were transfected gRNAs and ssODNs and cul-
tured for three days. DNA was isolated, PCR amplicons
of the targeted regions were sequenced and HDR scored as
the presence of the ssODN-derived mutations in the target
genes, which could have been introduced by classical ho-
mologous recombination or single-strand template repair.
When editing each gene independently, HDR frequencies
in the WT cells varied between 4% and 40% among the
14 genes (average 18%). In the KR cells, frequencies varied
between 15% and 81% (average 51%) (Figure 1A and B).
Across the genes, HDR is increased between 1.6-fold and
6.8-fold (average 3.3-fold) in KR cells (Figure 1C).
When deletions occurred at sites where the sequence on
one end of the deletion was identical to the undeleted se-
quence on the other end and was at least two nucleotides
longwe classified this asMMEJwhile other indels were con-
sidered to be the result of NHEJ. When compared to DNA-
PKcs WT cells, NHEJ and MMEJ decreased in KR cells
from an average of 31% to 4% (8.5-fold) and 29% to 17%
(1.7-fold), respectively (Figure 1A and B). The average ra-
tio of HDR to the sum of NHEJ andMMEJ was 0.3 inWT
cells and 6.5 in KR cells (Figure 1C). For all genes tested,
MMEJ is increased relatively to NHEJ in KR cells, regard-
less of the length of microhomology involved (Figure 1D).
Thus, in KR cells, NHEJ is inhibited, resulting in a drastic
increase of HDR, as schematically illustrated in Figure 1E.
For the three genes with the lowest HDR frequencies in
KR cells, MMEJ is the predominant editing event. To in-
crease HDR in those genes, we tried to use Cas9 instead
of Cas9n to induce chromosomal breaks. This increased
HDR for two genes from 35% and 20% to 73% and 87%,
respectively, while the MMEJ decreased for all three genes
(Supplementary Figure S1A). Thus, for some targets where
MMEJ predominates, PGE can be ‘rescued’ by using a dif-
ferent CRISPR enzyme, which uses different cleavage sites
and therefore possibly results in different tendencies for
MMEJ (Supplementary Figure S1B).
To test if the increase in HDR seen in the hiPSCs was
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the DNA-PKcs KR mutation in human embryonic kid-
ney cells (HEK293) and human immortalized myelogenous
leukemia cells (K562).When gRNAs and ssODNs (selected
from Figure 1 and a previous study (17)) are transfected to-
gether with Cas9 nickase, Cas9 or Cpf1 protein HDR in-
creased in all cell lines regardless of the enzyme used (Sup-
plementary Figure S1C), and regardless of if the enzyme
was transfected or endogenously produced by the cell (Fig-
ure 1A, B and Supplementary Figure S1A–C).
Simultaneous precise genome editing of multiple genes in the
same cell
We next electroporated gRNAs and the corresponding
donor DNAs (selected from Figure 1) for all pairwise com-
binations of four different genes into KR cells after induc-
tion of Cas9n expression. The HDR frequency of double
edits were similar or slightly lower than single edits of the
corresponding genes, regardless if both genes were located
on different chromosomes, on different chromosome arms,
or on the same chromosome arm (Figure 2A).We next tried
to simultaneously edit three, four and five genes. For three
different combinations of three genes, the HDR efficiency
was on average one third lower than for the single edits lead-
ing to average editing frequencies of 40% per targeted site
(Figure 2B). For four or five genes, average HDR frequen-
cies decreased to 13% and 8%, respectively (Figure 2C). Ad-
ditionally, cell survival decreased from 30–68% for two edits
to 11% for five edits (Figure 2E).
We isolated single cell-derived colonies (SCCs) from the
pools of edited cells. For triple edits, approximately a third
of SCCs carried the edited nucleotide in a homozygous form
at all genes targeted (six chromosomes) while this was the
case for 6% of SCCs for quadruple edits (eight chromo-
somes) (Figure 2D, Supplementary Tables S2–S5). Notably,
the percentage of cellular clones homozygous for all four in-
tended amino acid-changing substitutions (6%) is 1000-fold
higher than would be expected by chance if edits of the dif-
ferent genes would be independent of each other (0.006%),
suggesting that cells that are ‘editing competent’ will tend
to be efficiently edited at multiple sites.
Genome stability of cells expressing catalytically inactive
DNA-PKcs is not compromised
One concern is that inactivation of the catalytic activ-
ity of DNA-PKcs may lead to genomic instability be-
cause spontaneously occurring DSBs cannot be repaired
by NHEJ. We therefore analyzed the karyotypes of hiP-
SCs that had expressed DNA-PKcs KR for three months
by trypsin-Giemsa banding (GTG) and spectral karyotyp-
ing (SKY), which is able to detect smaller translocations.
All 25 metaphases analyzed by GTG and 49 out of 50 an-
alyzed by SKY had normal karyotypes (Figure 3B). Fur-
thermore, we treated cells expressing either DNA-PKcsWT
or KR with the DSB-inducing drug bleomycin to mimic
the effect of the accumulation of DSBs over long times. As
expected, bleomycin reduced cell survival. This effect was
twice as strong in DNA-PKcs KR expressing cells as inWT
cells (Supplementary Figure S2A). After bleomycin treat-
ment, 4 out of 50 metaphases analyzed in DNA-PKcs WT
cells contained unbalanced translocations with gain or loss
of chromosomal fragments, while 2 out of 50 metaphases
in DNA-PKcs KR cells contained balanced translocations
(Supplementary Figure S2B–E). In conclusion, we observe
no increase in aneuploidy or chromosomal rearrangements
in KR cells compared to WT cells.
To asses other types of genetic instability we sequenced
the genomes of three cellular clones: DNA-PKcs WT, its
descendent KR clone, and KR’s descendent triple-edited
KR-KSC clone (KATNA1-SLITRK1-CALD1 edited) (Fig-
ure 3A) to ∼24-fold genomic coverage. WT cells were pas-
saged 48 times before the KR clone was generated and KR
cells were passaged 24 times before the triple-edited clone
was generated (Figure 3A). Genotypes that appear in both
theKR clone and theKR-KSC clone and are different from
the WT clone are likely to be due to mutations that oc-
curred while DNA-PKcsWT was expressed, whereas geno-
types that appear only in the KR-KSC clone are likely to be
due to mutations that happened while DNA-PKcs KR was
expressed. To find big deletions and duplications we com-
pared genomic coverage per chromosome (Figure 3C) and
in 1 Mb windows along the chromosomes (Supplementary
Figure S3). The only difference found was a drop in cover-
age in one window on chromosome 9 in both KR and KR-
KSC clones compared to theWT indicating a heterozygous
deletion. After filtering for high-confidence genotypes (see
Methods) we looked for single nucleotide variants (SNVs)
and indels among clones. Surprisingly, the telomeric 41 Mb
on the short arm of chromosome 5 are devoid of heterozy-
gote positions in the KR and KR-KSC cells whereas it con-
tains 431 high-confidence heterozygous positions in theWT
cells. This is not due to a heterozygous deletion since there
is no drop in coverage and the karyotypes of chromosome 5
are normal.We speculate that this is due to a break-induced
repair event, which is described in yeast and has recently
been proposed to occur also in mammalian cells (41). Ex-
cluding the 41Mb on chromosome 5, we found 19 novel het-
erozygous SNVs shared between theKR andKR-KSC cells
and three novel heterozygous SNVs in the KR-KSC cells
(Figure 3D). We found no indels that differed among the
three cell lines, even though we find indels shared among
them. Extrapolated to the whole genome, the rate of mu-
tation fixation per passage is 21 in WT cells and 7 in KR
cells.
Transient inactivation of DNA-PKcs by small molecule
M3814
We note that the efficiency with which nucleotide substitu-
tions can be introduced in KR cells makes it possible to re-
store the normal DNA-PKcs function once desired changes
have been introduced in the genome. We demonstrated this
by editing the PRKDC gene back to its wildtype state and
find that this ‘back mutation’ can be introduced in 74% of
chromosomes (Figure 1B). An alternative way to increase
HDR may be to transiently inhibit the kinase activity of
DNA-PKcs. Indeed, several small molecule inhibitors of
DNA-PK have been described tomoderately increase HDR
(17,25). We tested this approach using M3814 (42), a novel
more efficient DNA-PKcs inhibitor which has not previ-
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Figure 4. Effects of transient inactivation of DNA-PKcs by the small molecule M3814. (A) Resazurin assay for cell survival in K562 cells 3 days after
editing of FRMD7 with Cas9 protein and treatment with different concentrations of M3814. (B) Genome editing efficiencies of FRMD7 with Cas9 protein
in K562 cells treated with different concentrations of M3814, and in 409B2 hiPSCs with 2 M M3814. M3814 was added for 3 days after editing. HDR,
mix (HDR with indels), NHEJ, and MMEJ are indicated in green, light green, light blue and light purple, respectively. Error bars show the SEM of six
replicates for A, three replicates for K562 cells for B, and two replicates for 409B2 hiPSCs for B.
DSB in K562 cells expressing wildtype DNA-PKcs M3814
increased HDR from 18% to 81% while exhibiting moder-
ate toxicity. A comparable increase of HDR is seen in 409B2
hiPSCs (Figure 4A and B). The HDR increase when using
M3814 is stronger than when using the previously described
DNA-PK inhibitor NU7026 (4- versus 1.7-fold) (Supple-
mentary Figure S4A).
To explore if this apparent high editing efficiency might
be due to induction of large deletions of the target DNA se-
quences (43), we isolated cellular clones by single-cell print-
ing after editing without and with M3814. By amplicon se-
quencing, we find that 10% of clones have homozygously
incorporated the desired nucleotide substitution in an ap-
parent diploid state when M3814 is not used whereas 76%
have done so when M3814 is used (Supplementary Figure
S5A and B). By long-range and quantitative PCR we found
CRISPR-induced deletions in 2% of clones and apparent
gains of one copy of the target locus in 6%of clones. The lat-
ter cases could be due to the duplication of the entire chro-
mosome X, one of the most frequent aneuploidies in stem
cells (44), or to erroneous repair of CRISPR-inducedDSBs.
M3814 similarly increased HDR in several other genes
and allowed for simultaneous multiple editing (data not
shown). Thus, inhibition of the kinase activity of DNA-
PKcs either by the reversible K3753R mutation or by the
kinase inhibitorM3814 substantially increases PGE and al-
lows the introduction ofmultiple nucleotide substitutions in
human cells.
DISCUSSION
The approach described here makes it possible to simulta-
neously edit multiple target genes in a single cell much more
efficiently than is currently possible. This will facilitate the
testing and potentially the correction of multiple interact-
ing disease-related genetic variants as well as the analyses
of interacting variants of physiological or evolutionary in-
terest. In fact, PGE as described here can presumably be
made even more efficient by combining it with other ap-
proaches that increase PGE, for example with combinations
of small molecules (Supplementary Figure S4B and C) (17).
It is likely to be applicable not only in humans but also other
vertebrates because the lysine residue at position 3753 in
DNA-PKcs is conserved among vertebrates (45).
It is interesting that we find no evidence that the K3753R
mutation decreases genome stability. In fact, we find fewer
translocations after bleomycin treatment, and fewer muta-
tions per passage, in themutant cells than in theDNA-PKcs
WT cells. Although this could be due to unknown differ-
ences among the cell lines, it is tempting to speculate that the
impairment of the error-prone NHEJ may cause the cells to
more frequently repair DSBs by the less error-prone HDR.
If this fails, cells may undergo apoptosis, resulting in that
surviving cells maintain their genome in a more accurate
form.
The fact that the DNA-PKcs inhibitor M3814 is able to
increase HDR to an extent comparable to what is achiev-
able by the PRKDCmutation (Figure 4) is encouraging be-
cause M3814 can be used to transiently inhibit NHEJ and
thus make the modification of PRKDC unnecessary. It is
also encouraging for work in whole organisms because per-
manent DNA-PKcs inactivation results in severe combined
immunodeficiency in mammals due to inability to carry out
V(D)J recombination (24). Indeed, M3814 is in phase Ib/II
clinical trials for treatment of various cancers, for exam-
ple small cell lung cancer (NCT03116971) and rectal cancer
(NCT03770689). If safe in humans, M3814 could therefore
find use in gene therapy applications where high HDR effi-
ciencies may be needed to achieve therapeutic goals.
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